1. Selecting TagSNPs in Candidate Genes for Genetic Association Studies Shehnaz K. Hussain, PhD, ScM Assistant Professor Department of Epidemiology, UCLA skhussain@ucla.edu Epidemiology 244: Cancer Epidemiology Methods

2. Objectives  Molecular genetics primer  Databases and tools to conduct in silico analyses for tagSNP selection/prioritization

3. Central dogma DNA Protein mRNA A T C G

4. What are SNPs?  More than 99% of all nucleotides are the same in all humans  1% of nucleotides are polymorphic  SNPs>> insertions-deletions  Bi-nucleotide – T (80%) A (20%)  Where do SNPs occur?  Exons  Introns  Flanking regions

5. ? T ? G ? A A T G G A A T T C G T A What are haplotypes?  A haplotype is the pattern of nucleotides on a single chromosome  Two “copies” of each chromosome  The haplotype inference problem TA TT CG GG TA AA

6. What is linkage disequilibrium?  Linkage disequilibrium (LD) describes the non- random association of nucleotides on the same chromosome in a population  One nucleotide at one position (locus) predicts the occurrence of another nucleotide at another locus No LD LD

7. Disease Susceptibility Locus Disease Phenotype Test for genetic association between the phenotype and the DSL Marker loci (SNPs) LD Test for association between phenotype and marker loci What are markers? Candidate gene

8. What are tagSNPs?  TagSNPs are a subset of all SNPs in a gene that mark groups of SNPs in LD  Avoids redundant genotyping Disease Susceptibility Locus LD Marker loci (SNPs)

9. The joint effect of tagSNPs in cytokine genes and cigarette smoking in cervical cancer risk

10. T-cell proliferation IL-2gene IFNγgene Activated T-cell Proliferation of TH1-cells IL-2 IFNγ IL-2 receptor IL-2gene Activated T-cell IL-2 -2gene Activated T-cell IL-2 -2 receptor IL-2 receptor IFNγgene IFNγ γgene IFNγ

11. Background  Cigarette smoking ↑ 1.5- to 3-fold cancer risk  Cigarette smoking ↓ levels of IL-2 and IFNγ (cervical and circulating)  ↓ levels of IL-2 and IFNγ  HPV persistence in the cervix  Cervical neoplasia  Decreased survival from invasive cervical cancer

12. Cigarette smoking HPV-associated squamous cell cervical cancer Model SNPs in IL-2, IL-2R, and IFNG

13.  Study design  Population-based case-only study  Subjects  308 Caucasian squamous cell cervical cancer cases diagnosed 1986-2004  Residing in 3 western Washington counties  Data collection  Structured in–person interviews  DNA isolated from buffy coats Methods

14. Multi-stage tagSNP design Re-sequence panel, identify SNPs (many markers, few subjects) Choose tagSNPs Genotype tagSNPs in main study (few markers, many subjects) Select reference panel

15.  A sample of your study population  Most representative  Samples from the Coriell Repository  Ability to integrate your data with other resources 1. Select reference panel = Candidate gene SNPs= HapMap SNPs

16. 2. Re-sequence reference panel PolyPhred Phred Phrap (Nickerson, 1997) (Ewing, 1998) Amplify and Sequence DNA Gene

17. Alternatives to re-sequencing  Program for Genomic Applications (PGA)  SeattleSNPs – inflammation  NIEHS SNPs – environmental response  Innate Immunity  International HapMap Project  5 million SNPs in four ethnically distinct populations

18. 3. Choose tagSNPs Option LDSelect (Carlson, 2002) Tagger (de Bakker, 2005) r 2 thresholdYes SNP exclusions/inclusionsNoYes SNP design scoreNoYes

19. LDSelect output for IL-2 SeattleSNPs, r 2 ≥0.80, MAF ≥0.05, Caucasian Bin Total Number of Sites TagSNPs 12 rs2069763 rs2069772 22 rs2069776 rs2069778 32 rs2069777 rs2069779 41rs2069762

20.  Exons (cSNPs)  SIFT (Ng, 2002)  PolyPhen (Ramensky, 2002)  Upstream flanking region  Intron-exon junctions Genomic context

21. Sequence conservation Repeat regionUnique region  UCSC Genome Browser, PhasCons (Siepel, 2005) Score

23. TagSNP summary  Efficient yet comprehensive coverage of the genetic variation in our candidate genes  Reduce costs  Preference should be given to putatively functional variants:  Literature, gene context, sequence conservation

24. Thanks for your attention! Questions?